Bandaram Pharma Packtech Ltd (BANDARAM) — shareholding pattern, promoter holding, financials and share price
About Bandaram Pharma Packtech Ltd (BANDARAM)
Bandaram Pharma Packtech Ltd operates in the Healthcare Service Provider industry, within the Healthcare sector. It trades on the NSE as BANDARAM and on the BSE under scrip code 524602. Its ISIN is INE875N01036.
Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper [1]
Bandaram Pharma Packtech Limited primarily focuses on the processing and supply of recycled paper to mills in Andhra Pradesh. Originally a latex glove manufacturer, the company has pivoted entirely to the paper industry since 2022.
The company meticulously ensures only high-quality recycled paper enters production, which supports efficient pulping for manufacturers. This includes sorting and baling consumer waste paper collected by hawkers and dealers.
Listed peers in Healthcare Service Provider: N G Industries Ltd, Deccan Health Care Ltd, Sharma East India Hosp and Medical Research Ltd, Samsrita Labs Ltd, Tejnaksh Healthcare Ltd, Chennai Meenakshi Multispeciality Hospital Ltd.
Valuation & Returns
10 Jul 2026At ₹24.78 a share on 10 Jul 2026, Bandaram Pharma Packtech Ltd (BANDARAM) was valued at a price-to-earnings ratio of 85.64x against an industry P/E of 61.73x and a price-to-book of 3.52x on a book value of ₹7.04 per share as of Mar 2025. Solomo computes return on equity of 4.11% and return on capital employed of 7.62% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 85.64x
- Industry P/E
- 61.73x
- P/B
- 3.52x
- EPS (TTM)
- ₹0.29
- Book value / share
- ₹7.04
- ROE
- 4.11%
- ROCE
- 7.62%
- ROA
- 1.34%
- Debt / equity
- 1.36x
- Dividend yield
- 0.4%
- EBITDA margin
- 4.64%
- 52-week range
- ₹20.95 – ₹49.7
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Bandaram Pharma Packtech Ltd (BANDARAM) reported revenue of ₹62.92 crore, net profit of ₹0.45 crore and earnings per share of ₹0.25. That compares with revenue of ₹36.96 crore and net profit of ₹0.99 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹26.26 crore and net profit ₹0.09 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 0 | 18.73 | 34.08 | 36.96 | 62.92 |
| Net profit (₹ cr) | -0.01 | 0.26 | 0.95 | 0.99 | 0.45 |
| EPS (₹) | -0.01 | 0.12 | 0.79 | 0.82 | 0.25 |
| Measure | 10Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | - | - | 8.45% |
| Profit growth | - | - | 4.21% |
| Stock price CAGR | 33% | -6% | -41% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 62.66% of Bandaram Pharma Packtech Ltd (BANDARAM) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹45 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: SANIVARAPU JHANSI 4.37%, SREEDAR REDDY G 2.23%, SANIVARAPU NAVYA REDDY 2.08%, KOLLI SURYATEJA REDDY . 1.86%, SAPNAA . 1.64%, VIVEK SURANA 1.49%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 62.66% | - | - | 0% | 37.34% |
| Mar 2026 | 62.66% | - | - | 0% | 37.34% |
| Dec 2025 | 62.62% | - | - | 0% | 37.38% |
| Sep 2025 | 75% | - | - | 0% | 25% |
| Jun 2025 | 75% | - | - | 0.01% | 25% |
| Mar 2025 | 75% | - | - | 0.01% | 25% |
| Dec 2024 | 75% | - | - | 0.01% | 25% |
| Sep 2024 | 75% | - | - | 0.01% | 25% |